Web-based Approach in Nutrition and Diabetes

May 13, 2020 updated by: Ester Vitacolonna, Università degli Studi 'G. d'Annunzio' Chieti e Pescara

Educational Approach, Clinical Nutrition and Type 2 Diabetes: Traditional Strategies and Innovative Technologies

The study aims to test web-based strategies, in overweight or obese participants at risk or affected by Type 2 Diabetes Mellitus , to promote adherence over time to a healthy lifestyle and nutritional medical therapy (TMN). The study population includes 40 subjects, randomly allocated to web group (therapeutic reinforcement through web-based strategies) or traditional group (traditional educational approach). Anthropometric and clinical parameters will be collected, as well as scores of validated questionnaires will be administered up to 12 months from the enrollment.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Chieti, Italy, 66100
        • Hospital "SS Annunziata"

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Overweight or obesity (BMI ≥25 kg/m2)
  • Participants with or at risk of Type 2 Diabetes Mellitus
  • Skills in the use web-based technologies and internet accessibility

Exclusion Criteria:

  • Conditions that could interfere with the execution and completion of the project or failure adherence to the protocol.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: WEB GROUP
Traditional approach integrated with web-based technologies.
Integration of "traditional" face-to-face educational approach with web-based technologies.
Other: TRADITIONAL GROUP
Traditional educational approach
"traditional" face-to-face educational approach

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in Body Weight
Time Frame: Baseline, month 3, month 6, month 9 and month12
Assessment of body weight (in kilograms) at baseline and after 3, 6, 9 and 12 months
Baseline, month 3, month 6, month 9 and month12

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in BMI
Time Frame: Baseline, month 3, month 6, month 9 and month12
Assessment of BMI (kg/m^2) at baseline and after 3, 6, 9 and 12 months
Baseline, month 3, month 6, month 9 and month12
Change from baseline in body circumferences
Time Frame: Baseline, month 3, month 6, month 9 and month12
Assessment of body circumferences (in centimeters) at baseline and after 3, 6, 9 and 12 months
Baseline, month 3, month 6, month 9 and month12
Change from baseline in Systolic and Diastolic blood pressure
Time Frame: Baseline, month 3, month 6, month 9 and month12
Assessment of Systolic and Diastolic blood pressure (mm hg) at baseline and after 3, 6, 9 and 12 months
Baseline, month 3, month 6, month 9 and month12
Change from baseline in fasting blood glucose
Time Frame: Baseline, month 3, month 6, month 9 and month12
Assessment of fasting blood glucose (mg/dl) at baseline and after 3, 6, 9 and 12 months
Baseline, month 3, month 6, month 9 and month12
Change from baseline in HbA1C
Time Frame: Baseline, month 3, month 6, month 9 and month12
Assessment of HbA1C at baseline and after 3, 6, 9 and 12 months
Baseline, month 3, month 6, month 9 and month12
Change from baseline in Dietary habits estimated by PREvencion con DIetaMEDiterranea questionnaire (PREDIMED questionnaire)
Time Frame: Baseline, month 3, month 6, month 9 and month12
Assessment of Dietary habits at baseline and after 3, 6, 9 and 12 months. Changes in dietary habits will be estimated using a 14-item PREDIMED questionnaire which is a questionnaire to assess the adherence to the Mediterranean diet, 0 being the minimum total score and 14 the maximum total score. Higher values represent a higher adherence to the Mediterranean diet.
Baseline, month 3, month 6, month 9 and month12
Change from baseline in physical activity level estimated by the International Physical Activity Questionnaire (IPAQ) - short form
Time Frame: Baseline, month 3, month 6, month 9 and month12
Assessment of physical activity level at baseline and after 3, 6, 9 and 12 months. Changes in the level of physical exercise will be estimated by the International Physical Activity Questionnaire (IPAQ-short form) which is a questionnaire to assess the level of physical activity. Patients are asked to measure the average amount of time spent in sedentary behaviours and different intensity levels of physical activity. The questionnaire obtains three different intensity levels of physical activity: low, moderate and high.
Baseline, month 3, month 6, month 9 and month12
Change from baseline in Quality of life by 36-item short form health survey (SF-36)
Time Frame: Baseline, month 3, month 6, month 9 and month12
Assessment of Quality of life by SF-36 at baseline and after 3, 6, 9 and 12 months. The 36-Item Short Form Health Survey (SF-36) is a self-report generic quality of life measure. The SF-36 measures eight scales: physical functioning (PF), role physical (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role emotional (RE), and mental health (MH) with scores ranging from 0 to 100. Higher scores indicate greater self-reported quality of life.
Baseline, month 3, month 6, month 9 and month12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 13, 2019

Primary Completion (Anticipated)

October 1, 2020

Study Completion (Anticipated)

October 1, 2020

Study Registration Dates

First Submitted

May 5, 2020

First Submitted That Met QC Criteria

May 8, 2020

First Posted (Actual)

May 13, 2020

Study Record Updates

Last Update Posted (Actual)

May 15, 2020

Last Update Submitted That Met QC Criteria

May 13, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Type 2 Diabetes Mellitus

Clinical Trials on web-based thecnologies

3
Subscribe